🇺🇸 FDA
Patent

US 9458095

Oligo-benzamide compounds and their use in treating cancers

granted A61KA61K31/167A61K31/24

Quick answer

US patent 9458095 (Oligo-benzamide compounds and their use in treating cancers) held by The Board of Regents of the University of Texas System expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/167, A61K31/24, A61K31/365, A61K45/06